The selective histamine H1-receptor agonist 2-(3-trifluoromethylphenyl)histamine increases waking in the rat

Add time:07/22/2019    Source:sciencedirect.com

The effects of the selective histamine H1-receptor agonist, 2-(3-trifluoromethylphenyl)histamine, were studied in rats implanted with electrodes for chronic sleep recordings. 2-(3-Trifluoromethylphenyl)histamine (80–120 μg) injected into the left lateral ventricle increased wakefulness, whereas slow wave sleep was reduced. Pretreatment with pyrilamine (2.0 mg/kg) prevented the effects of the H1-receptor agonist on wakefulness and slow wave sleep. Our results further support the involvement of histamine in the modulation of the waking state.

We also recommend Trading Suppliers and Manufacturers of (S)-1-(3-TRIFLUOROMETHYLPHENYL)-2-AMINOPROPANE (cas 19036-73-8). Pls Click Website Link as below: cas 19036-73-8 suppliers

Prev:Enantioselective synthesis of an unnatural bipyridyl amino acid and its incorporation into a peptide
Next:Antioxidant and antimicrobial activities of (6E, 10E)-2, 6, 24-trimethyl pentacosa-2, 6, 10-triene from Euclea crispa leaves)